Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 183 entries
View as:

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Phase: N/A Priority: Normal
NCT ID: NCT00126854 Org: User:
Start: 10/31/05 End: 04/30/11 Due: 04/30/12

Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function

Phase: N/A Priority: Normal
NCT ID: NCT05452824 Org: User:
Start: 06/21/21 End: 10/31/24 Due: 10/31/25

Study of Niacin in Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04677049 Org: User:
Start: 03/18/21 End: 01/31/26 Due: 01/31/27

p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

Phase: N/A Priority: Normal
NCT ID: NCT04104945 Org: User:
Start: 01/12/21 End: 10/21/28 Due: 10/21/29

Breast Cancer and Exercise Trial in Alberta

Phase: N/A Priority: Normal
NCT ID: NCT01435005 Org: User:
Start: 03/31/10 End: 06/30/14 Due: 06/30/15

Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone

Phase: N/A Priority: Normal
NCT ID: NCT00922519 Org: User:
Start: 06/18/09 End: 12/31/12 Due: 12/31/13

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Phase: N/A Priority: Normal
NCT ID: NCT02052102 Org: User:
Start: 10/31/14 End: 03/31/17 Due: 03/31/18

Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00127816 Org: User:
Start: 04/30/05 End: 04/30/13 Due: 04/30/14

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01514955 Org: User:
Start: 11/30/09 End: 12/31/11 Due: 12/31/12

Rosuvastatin in the Treatment of Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02569645 Org: User:
Start: 11/30/15 End: 09/24/21 Due: 09/24/22

Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00125697 Org: User:
Start: 05/31/05 End: 06/30/15 Due: 06/30/16

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00123786 Org: User:
Start: 08/31/05 End: 03/31/08 Due: 03/31/09

Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00291304 Org: User:
Start: 03/31/06 End: 01/31/10 Due: 01/31/11

The Feasibility of Physical Activity in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00438620 Org: User:
Start: 10/31/06 End: - Due: -

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01129310 Org: User:
Start: 07/31/10 End: 05/18/18 Due: 05/18/19

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02206230 Org: User:
Start: 09/25/14 End: 02/14/23 Due: 02/14/24

Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01495351 Org: User:
Start: 10/31/11 End: 02/10/15 Due: 02/10/16

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00907569 Org: User:
Start: 06/30/09 End: 04/30/11 Due: 04/30/12

Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

Phase: N/A Priority: Normal
NCT ID: NCT00351715 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

Phase: N/A Priority: Normal
NCT ID: NCT04358913 Org: User:
Start: 08/23/21 End: 01/31/29 Due: 01/31/30

Chemoradiotherapy for Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02297217 Org: User:
Start: 11/21/19 End: 04/30/25 Due: 04/30/26

Virtual Overdose Response

Phase: N/A Priority: Normal
NCT ID: NCT04391192 Org: User:
Start: 09/30/20 End: 02/28/21 Due: 02/28/22

Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00563407 Org: User:
Start: 07/31/06 End: 03/31/11 Due: 03/31/12

A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use

Phase: N/A Priority: Normal
NCT ID: NCT03145857 Org: User:
Start: 03/05/20 End: 08/31/46 Due: 08/31/47

Nutritional Supplementation in Head and Neck Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05379712 Org: User:
Start: 10/25/24 End: 10/31/26 Due: 10/31/27